Protagonist Therapeutics, Inc

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC PTGX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

104,528

Value ($000)

9,129

Weight

0.0%

2020 Q4 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	9,129	0.0%	104,528	12/31/2025
2025 Q3	11/14/2025	7,323	0.0%	110,229	9/30/2025
2025 Q2	8/14/2025	13,451	0.0%	243,373	6/30/2025
2025 Q1	5/19/2025	10,095	0.0%	208,756	3/31/2025
2024 Q4	2/14/2025	11,113	0.0%	287,911	12/31/2024
2024 Q3	11/14/2024	16,566	0.0%	368,132	9/30/2024
2024 Q2	8/14/2024	12,819	0.0%	369,955	6/30/2024
2024 Q1	5/15/2024	9,701	0.0%	335,318	3/31/2024
2023 Q4	2/14/2024	6,629	0.0%	289,079	12/31/2023
2023 Q3	11/13/2023	1,185	0.0%	71,059	9/30/2023
2023 Q2	8/11/2023	1,490	0.0%	64,778	6/30/2023
2023 Q1	5/15/2023	1,490	0.0%	64,778	3/31/2023
2022 Q3	11/14/2022	230	0.0%	27,275	9/30/2022
2022 Q2	8/12/2022	258	0.0%	32,664	6/30/2022
2022 Q1	5/16/2022	773	0.0%	32,664	3/31/2022
2021 Q4	2/14/2022	1,117	0.0%	32,664	12/31/2021
2021 Q3	11/15/2021	489	0.0%	27,598	9/30/2021
2021 Q2	8/16/2021	1,239	0.0%	27,598	6/30/2021
2021 Q1	5/14/2021	648	0.0%	25,000	3/31/2021
2020 Q4	3/1/2021	246	0.0%	12,200	12/31/2020